Synthesis of a novel series of non-symmetrical bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase

References

• Marrs TC. Organophosphate poisoning. Pharmacol Therapeut 1993; 58: 51–66
   PubMed Web of Science ®Google Scholar
• Bajgar J. Organophosphates/nerve agent poisoning: Mechanism of action, diagnosis, prophylaxis, and treatment. Adv Clin Chem 2004; 38: 151–216
   PubMed Web of Science ®Google Scholar
• Marklund A, Andersson B, Haglund P. Organophosphorus flame retardants and plasticizers in air from various indoor environments. J Environ Monit 2005; 7: 814–819
   PubMedGoogle Scholar
• Ringman JM, Cummings JL. Metrifonate (Trichlorfon): A review of the pharmacology, pharmacokinetics and clinical experience with a new acetylcholinesterase inhibitor for Alzheimer's disease. Opin Invest Drugs 1999; 8: 463–471
   Google Scholar
• Satoh T, Hosokawa M. Organophosphates and their impact on the global environment. Neurotoxicol 2000; 21: 223–227
   PubMed Web of Science ®Google Scholar
• Krivoy A, Layish I, Rotman E, Goldberg A, Yehezkelli Y. OP or not OP: the medical challenge at the chemical terrorism scene. Prehospital Disaster Med 2005; 20: 155–158
   PubMedGoogle Scholar
• Kassa J. The influence of anticholinergic drug and oxime selection on the effectiveness of antidotal treatment against tabun-induced poisoning in mice. Acta Medica 2002; 45: 75–78
   Google Scholar
• Petroianu GA, Hasan MY, Arafat K, Nurulain SM, Schmitt A. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): In vitro effect of tiapride. J Appl Toxicol 2005; 25: 562–567
   PubMed Web of Science ®Google Scholar
• Rousseaux CG, Dua AK. Pharmacology of HI-6, an H-series oxime. Can J Physiol Pharmacol 1989; 67: 1183–1189
   PubMed Web of Science ®Google Scholar
• Kassa J, Cabal J, Bajgar J, Szinicz L. The choice: HI-6,. pralidoxime or obidoxime against nerve agents?. ASA Newslett 1997; 97: 16–18
   Google Scholar
• Sevelova L, Kuca K, Krejcova-Kunesova G. Antidotal treatment of GF-agent intoxication in mice with bispyridinium oximes. Toxicol 2005; 207: 1–6
   PubMed Web of Science ®Google Scholar
• Kuca K, Kassa J. A comparison of the ability of new bispyridinium oxime 1-(4-hydroxyiminomethylpyridinium)-4-(4-carbamoylpyridinium)butane dibromide and currently used oximes to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vivo methods. J Enz Inhib Med Chem 2003; 18: 529–535
   PubMed Web of Science ®Google Scholar
• Kuca K, Patocka J. Reactivation of cyclosarin-inhibited rat brain acetylcholinesterase by pyridinium-oximes. J Enz Inhib Med Chem 2004; 19: 39–43
   PubMed Web of Science ®Google Scholar
• Kuca K, Jun D, Musilek K. Mini-Rev Med Chem 2006; 6: 269
   PubMed Web of Science ®Google Scholar
• Musilek K, Kuca K, Jun D, Dohnal V, Dolezal M. Synthesis of the novel series of bispyridinium compounds bearing (E)-but-2-ene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. Bioorg Med Chem Lett 2006; 16: 622–627
   PubMed Web of Science ®Google Scholar
• Musilek K, Kuca K, Jun D, Dohnal V, Dolezal M. Synthesis of a novel series of bispyridinium compounds bearing a xylene linker and evaluation of their reactivation activity against chlorpyrifos-inhibited acetylcholinesterase. J Enz Inhib Med Chem 2005; 20: 409–415
   PubMed Web of Science ®Google Scholar
• Manetsch R, Krasinski A, Radic Z, Raushel J, Taylor P, Sharpless KB, Kolb HC. In situ click chemistry: Enzyme inhibitors made to their own specifications. J Am Chem Soc 2004; 126: 12809–12818
   PubMed Web of Science ®Google Scholar
• Radic Z, Manetsch R, Krasinski A, Raushel J, Yamauchi J, Garcia C, Kolb H, Sharpless KB, Taylor P. Molecular basis of interactions of cholinesterases with tight binding inhibitors. Chem Biol Interact 2005; 157–158: 133–141
   PubMed Web of Science ®Google Scholar
• Patocka J, Cabal J, Kuca K, Jun D. Oxime reactivation of acetylcholinesterase inhibited by toxic phosporus ester: In vitro kinetics and thermodynamics. J Appl Biomed 2005; 3: 91–99
   Google Scholar
• Kuca K, Cabal J, Kassa J. A comparison of the potency of newly developed oximes (K005, K027, K033, K048) and currently used oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited rat brain acetylcholinesterase by in vitro methods. J Toxicol Env Health A 2005; 68: 677–686
   PubMed Web of Science ®Google Scholar
• Kuca K, Cabal J, Jun D, Kassa J, Bartosova L, Kunesova G. In vitro reactivation potency of some acetylcholinesterase reactivators against sarin- and cyclosarin-induced inhibitions. J Appl Toxicol 2005; 25: 296–300
   PubMed Web of Science ®Google Scholar
• Kuca K, Cabal J. Evaluation of newly synthesized reactivators of the brain cholinesterase inhibited by sarin nerve agent. Toxicol Mech Method 2005; 15: 247–252
   PubMed Web of Science ®Google Scholar
• Bajgar J, Patocka J. In vitro inhibition of soluble brain acetylcholinesterase by organophosphates of the O-ethyl-S-(dialkylaminoethyl)-methylphosphonothiolate type. Coll Czech Chem Commun 1977; 42: 770–776
   Google Scholar
• Cabal J, Kuca K, Kassa J. Specification of the structure of oximes able to reactivate tabun-inhibited acetylcholinesterase. Basic Clin Pharmacol Toxicol 2004; 95: 81–86
   PubMed Web of Science ®Google Scholar
• Ekstrom F, Akfur C, Tunemalm AK, Lundberg S. Biochemistry 2006; 45: 74–81
   PubMed Web of Science ®Google Scholar
• Tattersall JE. Ion channel blockade by oximes and recovery of diaphragm muscle from soman poisoning in vitro. Br J Pharmacol 1993; 108: 1006–1015
   PubMed Web of Science ®Google Scholar
• Kim TH, Kuca K, Jun D, Jung YS. Design and synthesis of new bis-pyridinium oxime reactivators for acetylcholinesterase inhibited by organophosphorous nerve agents. Bioorg Med Chem Lett 2005; 15: 2914–2917
   PubMed Web of Science ®Google Scholar
• Thiermann H, Szinicz L, Eyer F, Worek F, Eyer P, Felgenhauer N, Zilker T. Modern strategies in therapy of organophosphate poisoning. Toxicol Lett 1999; 107: 233–239
   PubMed Web of Science ®Google Scholar
• Worek F, Thiermann H, Szinicz L, Eyer P. Kinetic analysis of interactions between human acetylcholinesterase, structurally different organophosphorus compounds and oximes. Biochem Pharmacol 2004; 68: 2237–2248
   PubMed Web of Science ®Google Scholar
• Kuca K, Bielavsky J, Cabal J, Kassa J. Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase. Bioorg Med Chem Lett 2003; 13: 3545–3547
   PubMed Web of Science ®Google Scholar
• Pang YP, Kollmeyer TM, Hong F, Lee JC, Hammond PI, Haugabouk SP, Brimijoin S. Rational design of alkylene-linked bis-pyridiniumaldoximes as improved acetylcholinesterase reactivators. Chem Biol 2003; 10: 491–502
   PubMed Web of Science ®Google Scholar
• Chennamaneni SR, Vobalaboina V, Garlapati A. Quaternary salts of 4,3′ and 4,4′ bis-pyridinium monooximes: Synthesis and biological activity. Bioorg Med Chem Lett 2005; 15: 3076–3080
   PubMed Web of Science ®Google Scholar
• Srinivas Rao C, Venkateswarlu V, Achaiah G. Quaternary salts of 4,3′ and 4,4′ bis-pyridinium monooximes. Part 2: Synthesis and biological activity. Bioorg Med Chem Lett 2006; 2134–2138
   PubMedGoogle Scholar
• Kenley RA, Howd RA, Mosher CW, Winterle JS. Nonquaternary cholinesterase reactivators. Dialkylaminoalkyl thioesters of alpha-ketothiohydroximic acids as reactivators of diisopropyl phosphorofluoridate inhibited acetylcholinesterase. J Med Chem 1981; 24: 1124–1133
   PubMed Web of Science ®Google Scholar
• Kenley RA, Bedford CD, Howd RA, Jackson SE. Reactivation of ethyl methylphosphonylated eel acetylcholinesterase in vitro by 2PAM, H16, and a series of nonquaternary alpha-ketothiohydroximates. Biochem Pharmacol 1985; 34: 3606–3608
   PubMedGoogle Scholar